Vascular preventive medication usage according to indication in 2909 recent-onset Parkinson's disease cases
| Medication | Primary prevention | Secondary prevention | ||
|---|---|---|---|---|
| QRISK2 <10% =648 (22.3%) | QRISK2 ≥10% and <20% n=836 (28.7%) | QRISK2 ≥20% n=984 (33.8%) | n=441(15.2%) | |
| Statin | 42 (6.5%) | 126 (15.1%) | 366 (37.2%) | 332 (75.3%) |
| Antihypertensive | 96 (14.8%) | 236 (28.2%) | 533 (54.2%) | 345 (78.2%) |
| Antiplatelet/anticoagulant | 15 (2.3%) | 69 (8.3%) | 180 (18.3%) | 279 (63.3%) |
Data are number (percentage). QRISK2 is the 10-year future calculated cardiovascular risk.